MCF Advisors’s Biomerica BMRA Stock Holding History

MCF Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11	Hold	6	–	–	﹤0.01%	1398
2026 Q1	$13	Buy	+6	New	+$14	﹤0.01%	1330

Other funds holding BMRA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

MCF Advisors's BMRA Position: Q2 2026 in Review

MCF Advisors held its Biomerica (BMRA) position steady in Q2 2026 at 6 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

MCF Advisors first reported a position in BMRA in Q1 2026 and has held it in 2 quarters since. The position peaked at $13 in Q1 2026. 20 funds tracked by Wall St. Rank hold BMRA as of Q2 2026.

MCF Advisors held 6 shares of Biomerica worth $11 as of Q2 2026.
MCF Advisors left its Biomerica share count unchanged in Q2 2026.
Biomerica made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1398 holding.
MCF Advisors first reported a position in Biomerica in Q1 2026 and has held it in 2 quarters since.
MCF Advisors's Biomerica position peaked at $13 in Q1 2026.
20 funds tracked by Wall St. Rank held Biomerica as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.